Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in the treatment of locally advanced adenocarcinoma or adenosquamous carcinoma of the cervix uteri

The optimal treatment of women with locally advanced adenocarcinoma or adenosquamous carcinoma of the cervix uteri is still undefined. We report a series of four consecutive patients with locally advanced adeno- or adenosquamous carcinomas of the uterine cervix (FIGO Stages IB-IIIB) treated by concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by one to four cycles of consolidation chemotherapy with the same drug combination. After completion of this treatment all patients showed complete clinical remission. Now, after a median follow-up of 40 (range: 13.5-61) months all patients still present with no evidence of disease. Despite the low number of patients in this series we may conclude that concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy with the same drug combination is an efficacious treatment of patients with locally advanced adeno- or adenosquamous carcinomas of the cervix uteri.

Concomitant chemoradiation; Ifosfamide; Cisplatin; Consolidation chemotherapy; Adenocarcinoma of the cervix uteri; Adenosquamous carcinoma of the cervix uteri

[1] Parker S., Tong T., Bolden S. et al.: "Cancer statistic". CA Cancer J. Clin, 1996, 46, 5.

[2] Perez C.A., Kavanagh B.D.: "Uterine cervix". In: Perez C.A., Brady L.W., Halperin E.C., Schmidt-Ullrich R.K. (eds.). Principies and Practice of Radiation Oncology, 4'h ed., Philadelphia, Lippincott, Williams and Wilkins, 2004, 1800.

[3] National Cancer Institute: NCI Clinical Announcement. Betheseda, MD, United States Department of Health and Human Services, Public Health Service, National Institutes of Health, F ebruary 1999.

[4] Hong J.H., Tsai C.S., Wang C.C. et al.: "Comparison of clinical behaviors and responses to radiation between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas of the cervix". Changgeng Yi Xue Za Zhi, 2000, 23, 396.

[5] Kjorstad K.E.: "Adenocarcinoma of the uterine cervix". Gynecol Oneal., 1977, 5, 219.

[6] Saigo P.E., Cain J.M., Kim W.S. et al.: "Prognostic factor in carcinoma of the cervix: a matched analysis". Gynecol. Oncol., 1992, 44, 123.

[7] V rdoljak E., Prskalo T., Orurcen T. et al.: "Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix". Int. J. Rad. Oneal. Biol. Phys., 2004, 61, 824.

[8] Vermorken J.B.: "The role of chemotherapy in squamous cell carcinoma of the uterine cervix. A review". Int J Gynecol. Cancer, 1993, 3, 129.

[9] Tonkin K.S., Kelland L.R., Steel G.G.: "Chemotherapy-radiation interactions in human cervix carcinoma xenografts". Br. J. Cancer, 1988, 58, 738.

[10] Omura G.A., Blessing J.A., Vaccarelo L. et al.: "Randomised trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study". Int. Clin. Oneal., 1997, 15, 165.

[11] Keys H.M., Bundy B.N., Stehman F.B. et al.: "Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky Stage 1B cervical carcinoma". N. Engl. J. Med., 1999, 340, 1154.

[12] Whitney C.W., Sause W., Bundy B.N. et al.: "Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in Stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group Study". J. Clin Oncol., 1999, 17, 1339.

[13] Morris M., Eifel P.J., Lu J. et al.: "Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer". N. Engl. J. Med., 1999, 340, 1137.

[14] Rose P.G., Bundy B.N., Watkins E.B. et al.: "Concurrent cisplatinbased radiotherapy and chemotherapy for locally advanced cervical cancer". N. Engl. J. Med., 1999, 340, 1144.

[15] Lorvidhaya V., Tonusin A., Sukthomya W. et al.: "Induction chemotherapy and irradiation in advanced carcinoma of the cervix". Gan Kagaku Ryoho, 1995, 22 (suppl. 3), 244.

[16] Wong L.C., Ngan H.Y.S., Cheung A.N.Y. et al.: "Chemoradiation and adjuvant chemotherapy in cervical cancer". J. Clin. Oneal., 1999, 17, 2055.

[17] Green J.A., Kirwan J.M., Tierney J.F. et al.: "Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis" Lancet, 2001, 358, 781.

[18] Peters W.A., Liu P.Y., Barrett R.J. et al.: "Concurrent chemother apy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix". J. Clin. Oncol., 2000, 18, 1606.

[19] Chevalier T.L.: "Results of the randomized international adjuvant lung cancer trial (!ALT): cisplatin - based chemotherapy (CT) vs no CT in 1867 patients with resected non-small cell lung cancer (NSCLC) (abstract 6)". Proc. Am. Soc. Clin. Oncol., 2003, 22.

[20] Kato H. et al.: "A randomized phase III trial of adjuvant chemotherapy with UF T for completely resected pathological Stage I (TINOMO, T 2 NOMO) adenocarcinoma of the lung" (abstract 2498). Proc. Am. Soc. Clin. Oncol., 2003, 22.

[21] Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. International multicentre pooled analysis of colon cancer trials (impact) investigators. Lancet, 2000, 345, 939.

[22] Eifel P.J., Burke T.W., Morris M. et al.: "Adenocarcinoma as an independent risk factor for disease reccurence in patients with Stage IB cervical carcinoma". Gynecol. Oncol., 1995, 59, 38.